Rotator Cuff Injury Treatment Market by Modality (Surgical (Arthroscopy, Shoulder Replacement, Tendon Repair), Physiotherapy (Braces, Cold Compression), Drug Therapeutics (Anti-inflammatory Drugs, Injections), Orthobiologics)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

The global Rotator Cuff Injury Treatment market size was estimated at USD 1.7 billion in 2022 and is expected to surpass around USD 2.4 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 6.0% during the forecast period 2022 to 2030.

The key factors fueling the growth of this market include an increase in sports-related shoulder injuries, technological advancements in arthroscopic surgical devices, increase in aging population with osteoarthritis, strong focus of players towards launch of highly advanced arthroscopic treatment devices. On the other hand, a dearth of skilled professionals, a high surgical treatment failure rate, and its high cost are major challenges faced by market players providing rotator cuff injury treatment products.

Report Scope of the Rotator Cuff Injury Treatment Market

COVID-19 Impact on the global rotator cuff injury treatment market

Elective surgeries, including orthopedic surgery, were canceled worldwide, allowing hospitals to accommodate more COVID-19 patients and completely focus on reducing the possible risk of infection among healthcare workers. According to The CovidSurg Collaborative, a 120-country research initiative formed to analyze the impact of the COVID-19 pandemic on surgeries, around 28.4 million elective surgeries worldwide will be canceled or postponed in 2020, based on 12 weeks of peak disruption to hospital services due to COVID-19. The market was also impacted due to restrictions on the organized temporary closure of surgical centers, hospital access restriction for non-essential care, limited access to clinics, implementation of social distancing measures, nationwide lockdowns, and the slowdown of in-patient flow and referrals.

Rotator Cuff Injury Treatment Market Dynamics

Driver: Rising number of sports-related shoulder injuries

Sports and shoulder-related physical activities can cause high stress on the shoulder leading to the development of rotator cuff tendonitis, resulting in shoulder pain and weakness, further limiting the movement of the arm. The upper extremities constitute one-third of the proportion of sports injuries. Athletes engaged in sports like baseball, tennis, handball, and volleyball experience an acute episode of trauma or such as falling. Such episodes can increase the severity of shoulder injuries, ranging from rotator cuff contusions and tendinopathies development in rotator cuff tears. Around 3.5 million sports injuries are registered in the US annually (Source: National Electronic Injury Surveillance System, data as of 2019).

Restraint: High costs associated with arthroscopic surgical procedures

The high cost of arthroscopic surgery is a major concern, especially in emerging markets like China and India, where only a smaller population is under insurance coverage. The average cost of outpatient shoulder arthroscopy treatment in India can range between USD 3000 to USD 5000. Such costly treatments have reduced the affordability of shoulder arthroscopy are limiting the growth of this market. Moreover, surgical settings across low resource income nations are highly reluctant to adopt novel products owing to a lack of awareness and affordability, thus expecting to hinder the growth of this market to a certain extent.

Opportunity: Novel orthobiologics in pipeline

Regenerative biologics is a rapidly growing segment that is anticipated to change the facet of sports orthopedics significantly. Despite the development of advanced sutures, the high failure rates encourage many researchers to opt for biological therapy to stimulate the healing of an injury. Many players such as Nephew, Zimmer, Johnson & Johnson (through its DePuy Division), and Stryker are strongly shifting their focus on expanding their product offering in this domain. Moreover, the emergence of many new players in the development of innovative regenerative biologics is likely to result in potentially promising treatment options for rotator cuff injuries.

For instance: In March 2020, Ortho Regenerative Technologies Inc. announced the positive results from a pivotal preclinical study of ORTHO-R Biopolymer. This mucoadhesive CHITOSAN-based biopolymer matrix acts as a biodegradable scaffold. It is mixed with the patients PRP to develop biologics which further aids in increasing the healing rates of tendon relator injuries. With continued advanced development in orthobiologics, invasive orthopedic surgeries are expected to shift towards a minimally invasive treatment approach that offers high tendon healing rates

Challenge: High failure rates of rotator cuff surgical treatment

The incidence of rotator cuff injuries is increasing and requires immediate surgical intervention to repair the tear. However, there is still a growing failure rate in the surgical treatment of rotator cuffs, thus being a major concern. Despite improvements in rotator cuff surgery techniques, the chances of re-tear rate remain above 20%, increasing with the severity of the tear, hindering the overall growth of the rotator cuff injury treatment market.

“The surgical or curative treatment to capture the largest share in rotator cuff injury treatment market, by type during the forecast period.”

The surgical treatment segment is expected to hold the largest share of the market, during the forecast period. This is attributable to the high adoption due to the increasing prevalence of rotator cuff injuries majorly among sportspersons and the availability of medical reimbursements for surgical treatment for rotator cuff rupture in the developed nations.

Additionally, the increase in the preference of shoulder arthroscopy for the treatment rotator cuff tear among surgeons and the growing awareness about the benefits associated with an arthroscopic repair such as lower risk of complications, quick recovery, low rate of post surgical infections are likely to play a significant role in propelling the growth of the segment.

North America is the largest regional market for rotator cuff injury treatment market

North America capture the largest share of the market. This is attributed to the continuous development and commercialization of novel rotator cuff injury treatment products, favorable reimbursement and insurance coverage for rotator cuff repair treatment, supportive government regulations for product commercialization, and significant participation in sports.

Additionally, the growing adoption of bracing products for preventive and post-operative patient care, and strong presence of several key players in the country with its orthobiologic products in pipeline are likely to contribute towards the dominant market position.

Some of the prominent players in the Rotator Cuff Injury Treatment Market include:

Arthrex (US), Stryker Corporation (US), Smith & Nephew (UK), Johnson & Johnson (DePuy Synthes) (US), Zimmer Biomet (US), CONMED Corporation (US), Integra LifeSciences Corporation (US), LimaCorporate (Italy), FH ORTHOPEDICS S.A.S. (France), Evolutis India Pvt Ltd. (India), DJO Global (US), 3S Ortho (France), Breg, Inc. (US), GPC Medical Ltd. (India), and Parcus Medical (US).

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Rotator Cuff Injury Treatment market

By Treatment

• Surgical treatment or curative treatment
• Arthroscopy (tendon repair)
• Traditional/Open surgeries
• Shoulder Replacement Surgery
• Open Tendon Repair or Transfer
• Physiotherapy or Palliative treatment
• Orthopedic braces
• Cold compression therapy
• Pharmaceutical drugs or preventive treatment
• Anti-inflammatory drugs & pain killers
• Injections
• Orthobiologics

By Geography

North America

• U.S.
• Canada

Europe

• Germany
• France
• United Kingdom
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America

Middle East & Africa (MEA)

• GCC
• North Africa
• South Africa
• Rest of Middle East & Africa

Key Points Covered in Rotator Cuff Injury Treatment Market Study:

• Growth of Rotator Cuff Injury Treatment in 2022
• Market Estimates and Forecasts (2017-2030)
•  Brand Share and Market Share Analysis
•  Key Drivers and Restraints Shaping Market Growth
•  Segment-wise, Country-wise, and Region-wise Analysis
•  Competition Mapping and Benchmarking
•  Recommendation on Key Winning Strategies
•  COVID-19 Impact on Demand for Rotator Cuff Injury Treatment and How to Navigate
•  Key Product Innovations and Regulatory Climate
•  Rotator Cuff Injury Treatment Consumption Analysis
•  Rotator Cuff Injury Treatment Production Analysis
•  Rotator Cuff Injury Treatment and Management